Corvus Pharmaceuticals, Inc. (CRVS)

Healthcare · Biotechnology · NASDAQ

Corvus Pharmaceuticals, Inc. (CRVS) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.17B and a free-cash-flow yield of -3.0%.

Market cap	$1.17B
Trailing P/E	—
FCF yield	-3.0%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live CRVS data on Nama Insights →